Lv4
420 积分 2023-05-08 加入
Efficacy and Safety of Immune Checkpoint Inhibitors in Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis
1个月前
已完结
Comparison of the Efficacy and Safety of Perioperative Immunochemotherapeutic Strategies for Resectable Non-small Cell Lung Cancer: a Systematic Review and Network Meta-analysis
2个月前
已完结
Neoadjuvant nivolumab plus chemotherapy versus chemotherapy for resectable NSCLC: subpopulation analysis of Chinese patients in CheckMate 816
3个月前
已完结
Intrathecal nivolumab and IL-2 for treatment of leptomeningeal metastases in EGFR-mutated lung adenocarcinoma
3个月前
已完结
Effect of one or two cycles of dual immunotherapy with nivolumab and ipilimumab in patients with mismatch repair-deficient rectal cancer (RESET-R): interim results from a multicentre, single-arm, phase 2 trial
5个月前
已完结
HER2 and urothelial carcinoma: current understanding and future directions
5个月前
已完结
Preclinical characterization and phase 1 results of TQB2102, a first-in-class HER2 biparatopic antibody-drug conjugate, in patients with advanced solid tumors
5个月前
已关闭
DART (NCI/SWOG S1609): Comprehensive Final Results from Dual Checkpoint Inhibition with CTLA-4 and PD-1 Blockade in Rare Cancers
5个月前
已关闭
Is there a future for Trop-2-targeted ADCs in urothelial carcinoma?
5个月前
已完结
Optimizing local control in the surgical management of bladder cancer
8个月前
已完结
皖公网安备34019202002308
